FindTrial
Sign In

Clinical study of end expiratory carbon dioxide monitoring in early detection of pulmonary circulation disorders

Clinical study of end expiratory carbon dioxide monitoring in early detection of pulmonary circulation disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065248
Enrollment
Unknown
Registered
2022-11-01
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung surgery

Interventions

Observation group:N/A

Sponsors

Sichuan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients who plan to undergo left-side or right-sided pneumonectomy (2) Age 40-75; (3) Weight 50-70kg; (4) The ASA is classified as Grade I-III.

Exclusion criteria

Exclusion criteria: (1) Patients who refused to participate in the trial (2) Have a history of serious heart, brain, lung, liver, kidney and metabolic diseases; (3) Previous history of abnormal surgical anesthesia; (4) Those who does not cooperate and cannot communicate.

Design outcomes

Primary

MeasureTime frame
PetCO2;PCO2;Waveform of end expiratory carbon dioxide;—

Countries

China

Contacts

Public ContactJinjun Shu

Sichuan Cancer Hospital

shujinjun@scszlyy.org.cn+86 13550207607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 18, 2026